Hepatitis C virus prevalence in the Netherlands: Migrants account for most infections

Epidemiology and Infection

Volumn 141, Issue 6, 2013, Pages 1310-1317

  Vriend, H J ^a,c   Van Veen, M G ^a   Prins, M ^b,c   Urbanus, A T ^b,c   Boot, H J ^a   Op De Coul, E L M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

HCV seroprevalence; hepatitis C; national estimation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENDEMIC DISEASE; FEMALE; HEMOPHILIA; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MIGRATION; NETHERLANDS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREVALENCE; QUALITY OF LIFE; SEROPREVALENCE;

ADOLESCENT; ADULT; AGED; FEMALE; HEPATITIS C; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; POPULATION SURVEILLANCE; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; TRANSIENTS AND MIGRANTS; YOUNG ADULT;

EID: 84876914817     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812001884     Document Type: Article

References (33)

1. World Health Organization. Hepatitis C: Factsheet no. 164, 2011 (http://www.who.int/mediacentre/factsheets/fs164/en/). Accessed 22 February 2012.
2. Muhlberger N, et al. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 2009; 9: 34.
3. Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe-a review. Eurosurveillance 2008; 13.
4. Veldhuijzen IK, Conyn-van Spaendonck MAE, Dorigo-Zetsma JW. Seroprevalence of hepatitis B and C in the Dutch population [in Dutch]. Infectieziekten Bulletin 1999; 10: 182-184.
5. Vriend HJ, et al. Hepatitis C virus seroprevalence in The Netherlands. European Journal of Public Health. Published online: 29 March 2012. doi:10.1093/eurpub/cks013.
6. Baaten GGG, et al. Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004. Journal of Medical Virology 2007; 79: 1802-1810.
7. Veldhuijzen IK, et al. Viral hepatitis in a multiethnic neighborhood in the Netherlands: results of a community-based study in a low prevalence country. International Journal of Infectious Diseases 2009; 13: e9-e13.
8. van den Berg CH, et al. Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users. European Journal of Epidemiology 2007; 22: 183-193.
9. van de Laar TJW, et al. Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands. Journal of Medical Virology 2005; 77: 509-518.
10. Posthouwer D, et al. Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment. Haemophilia 2005; 11: 270-275.
11. Schneeberger PM, et al. The prevalence and incidence of hepatitis C virus infections among dialysis patients in The Netherlands: a nationwide prospective study. Journal of Infectious Diseases 2000; 182: 1291-1299.
12. Schreuder I, et al. Seroprevalence of HIV, hepatitis B, and hepatitis C among opioid drug users on methadone treatment in the Netherlands. Harm Reduction Journal 2010; 7: 25.
13. van de Laar TJW, et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. Journal of Infectious Diseases 2007; 196: 230-238.
14. Urbanus AT, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 2009; 23: F1-F7.
15. Kretzschmar M. The prevalence of hepatitis C in The Netherlands. Notice VWS-IGZ 2004/02. Project V/210041 [in Dutch]. Bilthoven: RIVM, 2004.
16. De Angelis D, et al. An evidence synthesis approach to estimating hepatitis C Prevalence in England and Wales. Statistical Methods in Medical Research 2009; 18: 361-379.
17. Razali K, et al. Modelling and calibration of the hepatitis C epidemic in Australia. Statistical Methods in Medical Research 2009; 18: 253-270.
18. Remis RS. Modelling the incidence and prevalence of hepatitis C infection and its sequelae in Canada, 2007. Public Health Agency of Canada.
19. Van Den Berg C, et al. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction 2007; 102: 1454-1462.
20. Vriend HJ, et al. Sexually transmitted infections, including HIV, in the Netherlands in 2009. Bilthoven: RIVM, 2010. Report No.: 210261007.
21. van Veen MG, et al. National estimate of HIV prevalence in the Netherlands: comparison and applicability of different estimation tools. AIDS 2011; 25: 229-237.
22. UNAIDS Reference Group on Estimates MaP. Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections. AIDS 2002; 16: W1-14.
23. Lyerla R, et al. The 2005 Workbook: an improved tool for estimating HIV prevalence in countries with low level and concentrated epidemics. Sexually Transmitted Infections 2006; 82 (Suppl. 3): iii41-44.
24. Walker N, et al. The workbook approach to making estimates and projecting future scenarios of HIV/AIDS in countries with low level and concentrated epidemics. Sexually Transmitted Infections 2004; 80 (Suppl. 1): i10-13.
25. van der Klis FR, et al. Second national serum bank for population-based seroprevalence studies in the Netherlands. Netherlands Journal of Medicine 2009; 67: 301-308.
26. Mollema L, et al. PIENTER 2-project: second research project on the protection against infectious diseases offered by the national immunization programme in the Netherlands. Bilthoven: RIVM, 2009.
27. Van Sighem A, et al. Monitoring report 2011, human immunodeficiency virus (HIV) infection in the Netherlands. Amsterdam: Stichting HIV Monitoring, 2011.
28. Beuker RJ, et al. Surveillance of HIV infection among injecting drug users in the Netherlands: results Den Haag 2000 [in Dutch]. Bilthoven: RIVM, 2001. Report No.: 441100015.
29. Urbanus AT, et al. Hepatitis C in the general population of various ethnic origins living in the Netherlands: should non-Western migrants be screened? Journal of Hepatology 2011; 55: 1207-1214.
30. Health Council of the Netherlands. Committee on Hepatitis C. Detection and treatment of people with hepatitis C. Rijswijk: Health Council of the Netherlands, 1997. Report No.: 1997/19.
31. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. Journal of Hepatology 2008; 48: 148-162.
32. Mauss S, et al. (eds). Short Guide to Hepatitis C. Flying Publisher, 2012 (www.flyingpublisher.com).
33. Chopra S. Clinical features and natural history of hepatitis C virus infection. In: UpToDate, Waltham, MA, 2012 (www.uptodate.com).